ELI Insider Trading Activity and SEC Form 4 Filings
ELI insider trading summary
No open-market insider purchases or sales of Elite Pharmaceuticals Inc (ELI) have been reported on SEC Form 4 in the past 12 months.
Latest ELI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 21, 2009 | Trellus Management Company, LLC | 10% Owner | Sell | $9K (138,528 @ $0.06) |
| Jul 21, 2009 | Trellus Offshore Fund Ltd | 10% Owner | Sell | $9K (138,528 @ $0.06) |
| Jul 21, 2009 | Adam Usdan | 10% Owner | Sell | $9K (138,528 @ $0.06) |
| Jul 21, 2009 | Trellus Partners LP | 10% Owner | Sell | $9K (138,528 @ $0.06) |
| Jul 15, 2009 | Trellus Partners LP | 10% Owner | Sell | $39K (561,342 @ $0.07) |
| Jul 15, 2009 | Trellus Management Company, LLC | 10% Owner | Sell | $39K (561,342 @ $0.07) |
| Jul 15, 2009 | Adam Usdan | 10% Owner | Sell | $39K (561,342 @ $0.07) |
| Jul 15, 2009 | Trellus Offshore Fund Ltd | 10% Owner | Sell | $39K (561,342 @ $0.07) |
| Apr 8, 2009 | Trellus Management Company, LLC | 10% Owner | Sell | $51K (393,200 @ $0.13) |
| Apr 8, 2009 | Trellus Partners LP | 10% Owner | Sell | $51K (393,200 @ $0.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.